Results

Total Results: 5,434 records

Showing results for "stages".

5301. Disposition of Comments for Technical Brief 23 Genetic Testing (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/genetic-testing-developmental-disabilities_disposition-comments.pdf
      June 30, 2015 - Disposition of Comments for Technical Brief 23 Genetic Testing Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder Draft review available for public comment from Dec…

5302. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
      September 25, 2013 - We appreciate the College’s involvement in this review (including earlier stages) and thank the 4 members

5303. Diabetes Mellitus (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
      December 01, 2015 - These health care interventions are still in the early stages of development or adoption, except in

5304. Improving Healthcare Through AHRQ's Digital Healthcare Research Program: 2021 Year in Review (pdf file)
      digital.ahrq.gov/sites/default/files/docs/page/ahrq-dhr-2021-year-in-review.pdf
      January 01, 2021 - • Exploratory and developmental research grants that support research in the early and conceptual stages

5305. Chapter-3 - Sepsis Recognition (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/sepsis-1.pdf
      March 01, 2020 - are shared by many other conditions, making sepsis difficult to diagnose, especially in the early stages

5306. Noninvasive Treatments for Low Back Pain (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_research_executive.pdf
      February 01, 2016 - The efficacy of manual therapy and exercise for different stages of non-specific low back pain: an

5307. Nis 2008 Maskedstats Severity (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Severity.PDF
      January 01, 2008 - please refer to the section on Description of Data Elements. For more information about the coding of HCUP data elements, HCUP Summary Statistics Report: NIS 2008 - Severity File 10:20 Monday, May 24, 2010 1 Means of Continuous Data Elements please refer to the section on Description of Data Elements. For more info…

5308. Nis 2009 Maskedstats Severity (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Severity.PDF
      January 01, 2009 - please refer to the section on Description of Data Elements. For more information about the coding of HCUP data elements, HCUP Summary Statistics Report: NIS 2009 - Severity File 19:13 Monday, May 16, 2011 1 Means of Continuous Data Elements please refer to the section on Description of Data Elements. For more infor…

5309. Kid 2009 Maskedstats Severity (pdf file)
      hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Severity.PDF
      January 01, 2009 - please refer to the section on Description of Data Elements. For more information about the coding of HCUP data elements, HCUP Summary Statistics Report: KID 2009 - Severity File 12:46 Wednesday, May 18, 2011 1 Means of Continuous Data Elements please refer to the section on Description of Data Elements. For more i…

5310. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
      March 15, 2007 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary: NSAIDs Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication March 15, 2007 Recommendations made by the USPSTF are independen…

5311. Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
      March 01, 2007 - Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task For…

5312. Migraine-Adults-Executive-130408 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
      April 01, 2013 - 1 Comparative Effectiveness Review Number 103 Migraine in Adults: Preventive Pharmacologic Treatments Executive Summary Introduction According to the International Classification of Headache Disorder, migraine is a common disabling primary headache disorder manifesting in attacks lasting 4 to 72 hours.1,2 M…

5313. Data-Points-7-Tables1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables1.pdf
      May 29, 2025 - 1 Table 1. Proportion of Beneficiaries With and Without Cancer Diagnosis Prior to First Biologics Order Among Beneficiaries Satisfying a Period of Continuous AB FFS Enrollment Prior to First Relevant Claim by Class of Drug, Active Ingredient, and Period of Continuous Enrollment, 2006-2009 Note: An asterisk (*) sign…

5314. Data-Points-7-Tables1 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables1.xls
      May 29, 2025 - OT.1 Table 1. Proportion of Beneficiaries With and Without Cancer Diagnosis Prior to First Biologics Order Among Beneficiaries Satisfying a Period of of Continuous AB FFS Enrollment Prior to First Relevant Claim by Class of Drug, Active Ingredient, and Period of Continuous Enrollment , 2006-2009 Note: A dash …

5315. ___APS-Def_Public.book (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/APS-DRGsDefManualV25Public.pdf
      June 01, 2009 - ___APS-Def_Public.book 4 0 0 C a p i t a l B o u l e v a r d • R o c k y H i l l , C T 0 6 0 6 7 • 1 - 8 0 0 - 9 9 9 - 3 7 4 7 D e f i n i t i o n s M a n u a l PUB 6.26.2009 APS-DRGs® ALL-PAYER SEVERITY-ADJUSTED DRG (APS-DRGS®) ASSIGNMENT FOR PUBLIC USE VERSION 25 COPYRIGHT PAGE Copyright © 2009 I…

5316. Continuous-Outcomes-Quantitative-Synthesis Methods (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
      March 01, 2011 - Methods Guide for Comparative Effectiveness Reviews Handling Continuous Outcomes in Quantitative Synthesis ii This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare…

5317. Sleep-Apnea Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_surveillance.pdf
      April 01, 2012 - AHRQ Comparative Effectiveness Review Surveillance Program CER #32: Diagnosis and Treatment of Obstructive Sleep Apnea in Adults Original release date: August 8, 2011 Surveillance Report: July, 2012 Key Findings: - The conclusions for KQ2 (phased testing), KQ3 (preoperative screening), KQ6 (compliance…

5318. Research Findings #24: Utilization and expenditures for children with special health care needs (pdf file)
      meps.ahrq.gov/data_files/publications/rf24/rf24.pdf
      January 01, 2006 - Research Findings #24: Utilization and expenditures for children with special health care needs Utilization and Expenditures for Children with Special Health Care Needs Agency for Healthcare Research and Quality U.S. Department of Health & Human Services January 2006 ( ) ( ) ( ) // / / // / ABSTRACT T…

5319. JAMA (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/pACFPdCoN8fVoddBs-_CLE
      November 12, 2019 - JAMA Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force IMPORTANCE Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) are associated with increased risk fo…

5320. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
      September 03, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Breast Cancer: Medication Use to Reduce Risk September 03, 2019 Recommendations made by the USPSTF are independent of the U.S. government. They should not be c…